首页|Pharmacokinetics and safety evaluation of oral Palonosetron in Chinese healthy volunteers: A phase 1, open-label, randomized, cross-over study
Pharmacokinetics and safety evaluation of oral Palonosetron in Chinese healthy volunteers: A phase 1, open-label, randomized, cross-over study
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NSTL
Elsevier
Purpose: Palonosetmn hydrochloride is a specific 5-HT3 receptor antagonist, used to prevent chemotherapy-induced nausea and vomiting (CINV), and is a known chemical entity currently registered in the oral and IV forms in several countries worldwide.
chemotherapy-induced nausea and vomitingpalonosetronpharmacokinetics5-HT3 receptor antagonist
NSTL
Elsevier
